AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This exploratory phase II study is designed to enroll patients with operable locally advanced head and neck squamous cell carcinoma, to observe the efficacy and safety of AK112 combined with chemotherapy as neoadjuvant therapy on them.
Epistemonikos ID: c3a32ba0caeb6ca05704bf0a1bb8ed8af40671da
First added on: Sep 01, 2024